IV International Conference on Novel Psychoactive Substances

We are pleased to announce that the Forth International Conference on Novel Psychoactive Substances (NPS):“NPS and Behavioural Addiction” will be held on 30th – 31st May 2016 in Budapest, Hungary.

The first three International Conferences on Novel Psychoactive Substances, respectively held in Budapest Swansea and Rome in 2012, 2013 and 2014, were extremely successful occasions to share knowledge and strengthen collaboration among multidisciplinary professionals. We are therefore delighted to announce the upcoming 4th International Conference on Novel Psychoactive Substances, that will take place in Budapest on May 30th-31th 2016.

It is being jointly organized by the University of Hertfordshire, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), “Sapienza” University of Rome, and the World Anti-Doping Agency (WADA) and the University of Chieti-Pescara.

The main objectives of this conference are:

• Sharing accurate, evidence-based information on NPS and latest trends of misuse;
• Improving understanding of treatment and management approaches for patients with levels of clinical and/or behavioural toxicity associated with NPS use;
• Assessing psychiatric consequences of NPS use and related behavioural addictions;
• Developing innovative prevention measures especially for vulnerable individuals;
• Raising awareness and contributing to the development of effective prevention messages;
• Exploring socio-cultural factors underlying risky behaviours;
• Contributing to the development of an international platform and other technological solutions for rapid information sharing;
• Defying new strategies to prevent the diffusion of NPS in society;
• Networking and providing the opportunity to meet renowned experts in the field

Сайт конференции: http://www.novelpsychoactivesubstances.org/

Register now for the

IV International Conference on Novel Psychoactive Substances (NPS)

Budapest 30-31st May 2016

Confirmed Speakers include:

• Roumen Sedefov and Paul Griffiths, EMCDDA: "How NPS changed the way we understand and respond to drugs”
• Ana Gallegos and Michel Evans-Brown, EMCDDA: "How did the EU EWS evolved in the last years and why?"
• Justice Tettey, UNODC Global SMART Programme: “NPS emergence, challenges and trends - the global perspective”
• Olivier Rabin, WADA: "Prohibited Substances in Sports: Emphasis on Counterfeit and Illegal Drugs of Abuse"
• Ornella Corazza, University of Hertfordshire, UK: “Highs and Whys: Self-Perception and Motivations of NPS Users"           
• Aviv Weinstein, University of Ariel, Israel: "The Effects of Synthetic cannabinoids on Executive Function and Related Brain Activity in fMRI”
• Owen Bowden-Jones, Imperial College, UK: "From club to clinic: How Should Clinicians Respond to the Challenge of NPS?”
• Anders Helander, Karolinska Institutet, Sweden: "New Drugs of Abuse Require New Testing Strategies”
• Zsolt Demetrovics, Eötvös Loránd University, “NPS in Hungary:An Historical Overview”    
• Giovanni Martinotti, Chieti-Pescara University, Italy: “NPS and Psychiatric Symptoms: Results from the Ibiza Study”
• Andy Parrott, Swansea University, UK: "The Perils of Ecstasy, Nicotine, and Other Pschoactive Drugs: An Overview of Forty Years Of Psychobiological Research".
• Fabrizio Schifano, University of Hertfordshire, UK: "Use of Novel Psychoactive Substances and the Risk of Psychopathological Disturbances”
• John Corkery, University of Hertfordshire, UK: "The Evolution and Characteristics of UK Deaths Involving GHB and its analogues"
• Giuseppe Bersani, Sapienza University, Italy: "NPS-Induced Changes in the Phenomenology of Psychiatric Diseases"
• Szendrei Kálmán, Szeged Medical University, Hungary:"NPS regulation: Running on the old treadmill, or designing a new concept and strategy?"
• Eva Keller, Semmelweis University, Hungary: "Forensic Case of Novel Psychoactive Substances”

To book on to this exciting conference visit our registration page.

ПАВ (4) новые наркотики (4)